Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,637 Cr
down ₹524 Cr vs Jan 2025
- Stocks held
- 36
- down 1 vs Jan 2025
- Top 10 weight
- 61.0%
- of the portfolio in its ten largest
- Cash & debt
- 1.1%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 7, trimmed 29
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In February 2025 it disclosed 36 stocks worth ₹7,637 Cr, down ₹524 Cr from Jan 2025. Its largest positions were Sun Pharmaceutical Industries Limited (13.7%), Divi's Laboratories Limited (9.3%), Lupin Limited (7.7%); the ten largest together made up 61.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.3% of its equity. Cash and debt stood at 1.1%. Compared with Jan 2025 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
15%
Holds more cash than 15% of peers
Holdings in February 2025
Download CSVEvery line the fund disclosed, with the change against Jan 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.68%
- Δ weight
- down 0.33 pts
- Value
- ₹1,045 Cr
- Δ value
- down ₹98.8 Cr
- Status
- Trimmed
- Weight
- 9.32%
- Δ weight
- up 0.09 pts
- Value
- ₹712 Cr
- Δ value
- down ₹41.7 Cr
- Status
- Trimmed
- Weight
- 7.73%
- Δ weight
- down 0.43 pts
- Value
- ₹590 Cr
- Δ value
- down ₹75.8 Cr
- Status
- Trimmed
- Weight
- 5.90%
- Δ weight
- up 0.28 pts
- Value
- ₹450 Cr
- Δ value
- down ₹8.2 Cr
- Status
- Trimmed
- Weight
- 5.35%
- Δ weight
- down 0.11 pts
- Value
- ₹409 Cr
- Δ value
- down ₹36.9 Cr
- Status
- Trimmed
- Weight
- 5.14%
- Δ weight
- down 0.27 pts
- Value
- ₹393 Cr
- Δ value
- down ₹49.2 Cr
- Status
- Trimmed
- Weight
- 3.82%
- Δ weight
- up 1.05 pts
- Value
- ₹292 Cr
- Δ value
- up ₹65.6 Cr
- Status
- Added
- Weight
- 3.41%
- Δ weight
- down 0.20 pts
- Value
- ₹260 Cr
- Δ value
- down ₹33.8 Cr
- Status
- Trimmed
- Weight
- 3.39%
- Δ weight
- up 0.23 pts
- Value
- ₹259 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 3.28%
- Δ weight
- up 1.26 pts
- Value
- ₹250 Cr
- Δ value
- up ₹85.8 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- down 0.04 pts
- Value
- ₹238 Cr
- Δ value
- down ₹20 Cr
- Status
- Trimmed
- Weight
- 3.11%
- Δ weight
- up 0.25 pts
- Value
- ₹237 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 2.84%
- Δ weight
- up 0.29 pts
- Value
- ₹217 Cr
- Δ value
- up ₹8.6 Cr
- Status
- Added
- Weight
- 2.36%
- Δ weight
- down 0.09 pts
- Value
- ₹180 Cr
- Δ value
- down ₹19.3 Cr
- Status
- Trimmed
- Weight
- 2.30%
- Δ weight
- down 0.08 pts
- Value
- ₹175 Cr
- Δ value
- down ₹18.7 Cr
- Status
- Trimmed
- Weight
- 2.15%
- Δ weight
- down 0.01 pts
- Value
- ₹164 Cr
- Δ value
- down ₹12 Cr
- Status
- Trimmed
- Weight
- 1.95%
- Δ weight
- down 0.29 pts
- Value
- ₹149 Cr
- Δ value
- down ₹33.8 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- down 0.07 pts
- Value
- ₹148 Cr
- Δ value
- down ₹16.2 Cr
- Status
- Trimmed
- Weight
- 1.69%
- Δ weight
- down 0.08 pts
- Value
- ₹129 Cr
- Δ value
- down ₹15.5 Cr
- Status
- Trimmed
- Weight
- 1.69%
- Δ weight
- down 0.03 pts
- Value
- ₹129 Cr
- Δ value
- down ₹11.6 Cr
- Status
- Trimmed
- Weight
- 1.59%
- Δ weight
- down 0.14 pts
- Value
- ₹121 Cr
- Δ value
- down ₹19.5 Cr
- Status
- Trimmed
- Weight
- 1.51%
- Δ weight
- down 0.05 pts
- Value
- ₹115 Cr
- Δ value
- down ₹11.8 Cr
- Status
- Trimmed
- Weight
- 1.39%
- Δ weight
- up 0.30 pts
- Value
- ₹106 Cr
- Δ value
- up ₹16.9 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- down 0.38 pts
- Value
- ₹101 Cr
- Δ value
- down ₹37.6 Cr
- Status
- Trimmed
- Weight
- 1.27%
- Δ weight
- up 0.05 pts
- Value
- ₹97.3 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 1.22%
- Δ weight
- up 0.34 pts
- Value
- ₹93.2 Cr
- Δ value
- up ₹21.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.11%
- Δ weight
- down 0.25 pts
- Value
- ₹84.9 Cr
- Δ value
- down ₹26.2 Cr
- Status
- Trimmed
- Weight
- 1.09%
- Δ weight
- down 0.11 pts
- Value
- ₹83.3 Cr
- Δ value
- down ₹14.8 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- down 0.07 pts
- Value
- ₹73.4 Cr
- Δ value
- down ₹10.6 Cr
- Status
- Trimmed
- Weight
- 0.90%
- Δ weight
- down 0.11 pts
- Value
- ₹69.1 Cr
- Δ value
- down ₹13.7 Cr
- Status
- Trimmed
- Weight
- 0.87%
- Δ weight
- down 0.14 pts
- Value
- ₹66.8 Cr
- Δ value
- down ₹15.7 Cr
- Status
- Trimmed
- Weight
- 0.62%
- Δ weight
- down 0.23 pts
- Value
- ₹47.4 Cr
- Δ value
- down ₹22.3 Cr
- Status
- Trimmed
- Weight
- 0.56%
- Δ weight
- down 0.01 pts
- Value
- ₹42.9 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- down 0.09 pts
- Value
- ₹36.1 Cr
- Δ value
- down ₹9.8 Cr
- Status
- Trimmed
- Weight
- 0.39%
- Δ weight
- down 0.07 pts
- Value
- ₹29.5 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 0.32%
- Δ weight
- down 0.03 pts
- Value
- ₹24.1 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 0.22%
- Δ weight
- down 0.08 pts
- Value
- ₹16.7 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
What changed, Jan 2025 to Feb 2025
New New positions (0)
None.
Exited Exited (1)
- Healthcare Global Enterprises Limitedwas 0.4% · ₹29.3 Cr
Added Biggest additions
- GlaxoSmithKline Pharmaceuticals Limitedup ₹85.8 Cr (+1.26% pts)
- Abbott India Limitedup ₹65.6 Cr (+1.05% pts)
- Sai Life Sciences Limitedup ₹21.7 Cr (+0.34% pts)
- IPCA Laboratories Limitedup ₹16.9 Cr (+0.30% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2025, the weight rose most in Pharmaceuticals & Biotechnology (+1.3 pts) and Retailing (+0.2 pts), and fell most in Healthcare Services (−1.5 pts).
- Pharmaceuticals & Biotechnology77.0% → 78.3%+1.3 pts
- Retailing3.2% → 3.4%+0.2 pts
- Healthcare Services19.2% → 17.7%−1.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2022 | Feb 2024 | Aug 2024 | Nov 2024 | Jan 2025 | Feb 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.8% | 78.9% | 79.0% | 76.7% | 77.0% | 78.3% |
| Healthcare Services | 21.8% | 17.2% | 17.7% | 19.3% | 19.2% | 17.7% |
| Retailing | — | 3.1% | 2.5% | 3.3% | 3.2% | 3.4% |
| Pharmaceuticals | 2.0% | 0.9% | 0.8% | 0.7% | 0.6% | 0.5% |
Allocation in Feb 2025change vs Jan 2025
- Pharmaceuticals & Biotechnology (25)78.3%▲ 1.3 pts
- Healthcare Services (9)17.7%▼ 1.5 pts
- Retailing (1)3.4%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2025
1.1%
▼ 0.3 pts vs Jan 2025
- Cash alone
- 1.1%
- cash and net receivables
- A year earlier
- 2.1%
- Feb 2024 · now ▼ 0.9 pts
- Last 12 months
- 0.6% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.